110 related articles for article (PubMed ID: 3381232)
1. Isomers of 10-hydroxynortriptyline in geriatric depression.
Young RC; Dhar AK; Kutt H; Alexopoulos GS
Ther Drug Monit; 1988; 10(2):164-7. PubMed ID: 3381232
[TBL] [Abstract][Full Text] [Related]
2. Plasma 10-hydroxynortriptyline in elderly depressed patients.
Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.
McCue RE; Georgotas A; Nagachandran N; Abdul Basir M; Go EA; Suckow RF; Cooper TB
J Psychiatr Res; 1989; 23(1):73-9. PubMed ID: 2754630
[TBL] [Abstract][Full Text] [Related]
4. Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.
Young RC; Alexopoulos GS; Shindledecker R; Dhar AK; Kutt H
Neuropsychopharmacology; 1988 Sep; 1(3):213-5. PubMed ID: 3251501
[TBL] [Abstract][Full Text] [Related]
5. Nortriptyline response in elderly depressed patients.
Kanba S; Matsumoto K; Nibuya M; Suzuki E; Kinoshita N; Shintani F; Yagi G
Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):301-9. PubMed ID: 1589587
[TBL] [Abstract][Full Text] [Related]
6. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
McCue RE; Georgotas A; Suckow RF; Cooper TB
J Neuropsychiatry Clin Neurosci; 1989; 1(2):176-80. PubMed ID: 2521060
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
Nordin C; Bertilsson L; Siwers B
Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
[TBL] [Abstract][Full Text] [Related]
9. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
Dawling S; Lynn K; Rosser R; Braithwaite R
Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
[TBL] [Abstract][Full Text] [Related]
10. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
[TBL] [Abstract][Full Text] [Related]
11. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.
Pollock BG; Everett G; Perel JM
Neuropsychopharmacology; 1992 Jan; 6(1):1-10. PubMed ID: 1571065
[TBL] [Abstract][Full Text] [Related]
12. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
[TBL] [Abstract][Full Text] [Related]
13. Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.
Young RC; Alexopoulos GS; Shamoian CA; Kent E; Dhar AK; Kutt H
Am J Psychiatry; 1985 Jul; 142(7):866-8. PubMed ID: 4014510
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
[TBL] [Abstract][Full Text] [Related]
15. Amitriptyline metabolism in relation to antidepressive effect.
Edelbroek PM; Zitman FG; Schreuder JN; Rooymans HG; de Wolff FA
Clin Pharmacol Ther; 1984 Apr; 35(4):467-73. PubMed ID: 6705444
[TBL] [Abstract][Full Text] [Related]
16. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
[TBL] [Abstract][Full Text] [Related]
17. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline.
Dahl ML; Nordin C; Bertilsson L
Ther Drug Monit; 1991 May; 13(3):189-94. PubMed ID: 1926270
[TBL] [Abstract][Full Text] [Related]
19. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatography-mass spectrometry for the quantification of nortriptyline and 10-hydroxynortriptyline in plasma.
Tybring G; Nordin J; Widén J
J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):382-6. PubMed ID: 9824256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
